Equipment may differ, formulas and hearing aids alter, but I am in agreement with what this article points out: the test box can be considered a vastly under-used and under-appreciated piece of equipment. It can provide an alternative verification for...
As our understanding of the pathophysiology of CRS evolves, so do our treatment strategies. It is accepted that in many cases, the main role of surgery is to allow better penetration of topical therapies to the sinus cavities. What, then,...
The development of next-generation drug-based approaches to treat inner ear disorders is gaining momentum, with multiple INDs approved in the last six months and big pharma making plays to acquire innovative biotechs working on hearing loss. The 3rd Inner Ear...
The First World War marked a pivotal moment in the understanding and treatment of hearing loss and deafness. Prior to the war, deafness had been largely attributed to congenital causes. This view was influenced by a negative eugenic Darwinist ideology...
1 September 2018
| Dubhfeasa Máire Slattery
|
ENTA - General
The first Professor and Chair of Medical Professionalism at RCSI and BSHS, Dubhfeasa Slattery provides an overview of how a desire for better healthcare at all levels can be harnessed and nourished, leading to a potential life-long interest in reducing...
Motor Neurone Disease (MND) is a progressive neurological condition that affects motor neurons in the brain, brainstem and spinal cord, affecting the control of skeletal muscles for speech, chewing and swallowing. There are two variants of MND, with symptoms typically...
Thinking of going back to university to do further study? We hear from one audiologist who identified an area of further study and specialisation and took the leap. My career in audiology began in 2003 through a traditional route in...
Whilst rare, squamous cell carcinoma is the commonest primary malignancy of the temporal bone and is discussed in this review article. This tumour frequently presents with otalgia, ottorhoea and hearing loss; less commonly, with facial palsy or parotid mass. Investigations...
7 July 2020
| Rujuta Roplekar Bance, Olivia Ruskin, Kiersten Pianosi, Anika Kaura, Sheneen Meghji
|
ENTA - ENT
Here, ENT trainees share their experiences of adaptations to both clinical practice and training during the COVID-19 pandemic. We welcome other colleagues from around the world to share their experiences with us via social media or the website. Australia Olivia...
Neuromod Devices Ltd, the Irish medical device company which specialises in neuromodulation technologies, has announced the establishment of Neuromod USA Inc., a subsidiary headquartered in Oak Brook, Illinois.
Optimal management of cleft lip and palate requires a multidisciplinary team approach to treatment, with the goal being maintenance of facial growth and improvement in speech and hearing, in addition to closure of the cleft. This can be especially challenging...
Neuromod has announced that clinically proven tinnitus treatment device, Lenire, is now available in Malaga, Seville and Granada through partnership with medical technology distributor, TRUSBIN.